| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear speck | 6.67e-04 | 431 | 9 | 3 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 5.55e-03 | 903 | 9 | 3 | GO:0016604 | |
| Domain | TSP_1 | 3.97e-04 | 63 | 9 | 2 | PF00090 | |
| Domain | TSP1_rpt | 4.23e-04 | 65 | 9 | 2 | IPR000884 | |
| Domain | TSP1 | 4.23e-04 | 65 | 9 | 2 | PS50092 | |
| Domain | TSP1 | 4.23e-04 | 65 | 9 | 2 | SM00209 | |
| Domain | EGF_3 | 5.35e-03 | 235 | 9 | 2 | PS50026 | |
| Domain | EGF-like_dom | 5.99e-03 | 249 | 9 | 2 | IPR000742 | |
| Domain | EGF_1 | 6.27e-03 | 255 | 9 | 2 | PS00022 | |
| Domain | EGF-like_CS | 6.56e-03 | 261 | 9 | 2 | IPR013032 | |
| Domain | EGF_2 | 6.76e-03 | 265 | 9 | 2 | PS01186 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 7.87e-06 | 1294 | 9 | 5 | 30804502 | |
| Pubmed | 2.03e-05 | 713 | 9 | 4 | 29802200 | ||
| Pubmed | 3.02e-05 | 251 | 9 | 3 | 31076518 | ||
| Pubmed | 5.60e-05 | 44 | 9 | 2 | 27505670 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 6.82e-05 | 330 | 9 | 3 | 33301849 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.04e-04 | 1082 | 9 | 4 | 38697112 | |
| Pubmed | 14-3-3sigma controls mitotic translation to facilitate cytokinesis. | 2.15e-04 | 86 | 9 | 2 | 17361185 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.22e-04 | 1318 | 9 | 4 | 30463901 | |
| Pubmed | 2.27e-04 | 496 | 9 | 3 | 31343991 | ||
| Interaction | LUC7L interactions | 2.30e-10 | 242 | 9 | 6 | int:LUC7L | |
| Interaction | CLK2 interactions | 9.84e-09 | 195 | 9 | 5 | int:CLK2 | |
| Interaction | SRSF4 interactions | 8.48e-08 | 300 | 9 | 5 | int:SRSF4 | |
| Interaction | SAP18 interactions | 9.21e-08 | 305 | 9 | 5 | int:SAP18 | |
| Interaction | RNPS1 interactions | 4.79e-07 | 425 | 9 | 5 | int:RNPS1 | |
| Interaction | SNRPC interactions | 5.68e-07 | 440 | 9 | 5 | int:SNRPC | |
| Interaction | CLK4 interactions | 8.08e-07 | 44 | 9 | 3 | int:CLK4 | |
| Interaction | SNRPA interactions | 8.92e-07 | 482 | 9 | 5 | int:SNRPA | |
| Interaction | SRSF6 interactions | 1.10e-06 | 503 | 9 | 5 | int:SRSF6 | |
| Interaction | CLK1 interactions | 1.64e-06 | 219 | 9 | 4 | int:CLK1 | |
| Interaction | MECP2 interactions | 4.76e-06 | 1287 | 9 | 6 | int:MECP2 | |
| Interaction | DHX8 interactions | 5.14e-06 | 292 | 9 | 4 | int:DHX8 | |
| Interaction | SRPK2 interactions | 6.29e-06 | 717 | 9 | 5 | int:SRPK2 | |
| Interaction | RBMX2 interactions | 1.00e-05 | 101 | 9 | 3 | int:RBMX2 | |
| Interaction | MAGEB2 interactions | 1.04e-05 | 349 | 9 | 4 | int:MAGEB2 | |
| Interaction | SNIP1 interactions | 2.10e-05 | 417 | 9 | 4 | int:SNIP1 | |
| Interaction | ZNF816 interactions | 2.12e-05 | 16 | 9 | 2 | int:ZNF816 | |
| Interaction | SRSF7 interactions | 2.26e-05 | 425 | 9 | 4 | int:SRSF7 | |
| Interaction | PABPC5 interactions | 2.79e-05 | 142 | 9 | 3 | int:PABPC5 | |
| Interaction | SNRNP70 interactions | 2.94e-05 | 984 | 9 | 5 | int:SNRNP70 | |
| Interaction | DDX23 interactions | 3.64e-05 | 480 | 9 | 4 | int:DDX23 | |
| Interaction | ZNF543 interactions | 3.71e-05 | 21 | 9 | 2 | int:ZNF543 | |
| Interaction | PRPF38A interactions | 4.06e-05 | 161 | 9 | 3 | int:PRPF38A | |
| Interaction | SNRPB interactions | 4.87e-05 | 517 | 9 | 4 | int:SNRPB | |
| Interaction | CPSF6 interactions | 5.21e-05 | 526 | 9 | 4 | int:CPSF6 | |
| Interaction | SON interactions | 8.70e-05 | 208 | 9 | 3 | int:SON | |
| Interaction | ZC3H11A interactions | 9.59e-05 | 215 | 9 | 3 | int:ZC3H11A | |
| Interaction | NUP43 interactions | 1.02e-04 | 625 | 9 | 4 | int:NUP43 | |
| Interaction | CLK3 interactions | 1.03e-04 | 220 | 9 | 3 | int:CLK3 | |
| Interaction | PURG interactions | 1.07e-04 | 223 | 9 | 3 | int:PURG | |
| Interaction | SNRNP40 interactions | 1.10e-04 | 637 | 9 | 4 | int:SNRNP40 | |
| Interaction | DHX40 interactions | 1.48e-04 | 249 | 9 | 3 | int:DHX40 | |
| Interaction | MAGOH interactions | 1.76e-04 | 264 | 9 | 3 | int:MAGOH | |
| Interaction | HNRNPUL2 interactions | 2.35e-04 | 291 | 9 | 3 | int:HNRNPUL2 | |
| Interaction | PNN interactions | 2.62e-04 | 302 | 9 | 3 | int:PNN | |
| Interaction | MZT1 interactions | 3.20e-04 | 61 | 9 | 2 | int:MZT1 | |
| Interaction | TRA2A interactions | 3.40e-04 | 330 | 9 | 3 | int:TRA2A | |
| Interaction | NXF2 interactions | 3.63e-04 | 65 | 9 | 2 | int:NXF2 | |
| Interaction | ZC3H18 interactions | 3.77e-04 | 877 | 9 | 4 | int:ZC3H18 | |
| Interaction | LUC7L2 interactions | 4.14e-04 | 353 | 9 | 3 | int:LUC7L2 | |
| Interaction | ZRSR2 interactions | 5.10e-04 | 77 | 9 | 2 | int:ZRSR2 | |
| Interaction | NKTR interactions | 6.96e-04 | 90 | 9 | 2 | int:NKTR | |
| Interaction | ATXN1 interactions | 7.18e-04 | 1039 | 9 | 4 | int:ATXN1 | |
| Interaction | RBM39 interactions | 7.26e-04 | 1042 | 9 | 4 | int:RBM39 | |
| Interaction | NFKBIL1 interactions | 7.43e-04 | 93 | 9 | 2 | int:NFKBIL1 | |
| Interaction | CPSF4 interactions | 7.59e-04 | 94 | 9 | 2 | int:CPSF4 | |
| Interaction | KHDRBS3 interactions | 7.59e-04 | 94 | 9 | 2 | int:KHDRBS3 | |
| Interaction | THRAP3 interactions | 8.03e-04 | 443 | 9 | 3 | int:THRAP3 | |
| Interaction | SRSF8 interactions | 8.24e-04 | 98 | 9 | 2 | int:SRSF8 | |
| Interaction | ZBTB2 interactions | 8.40e-04 | 450 | 9 | 3 | int:ZBTB2 | |
| Interaction | PRPF19 interactions | 8.40e-04 | 450 | 9 | 3 | int:PRPF19 | |
| Interaction | AKAP17A interactions | 8.41e-04 | 99 | 9 | 2 | int:AKAP17A | |
| Interaction | RAD18 interactions | 8.79e-04 | 457 | 9 | 3 | int:RAD18 | |
| Interaction | TRPC4AP interactions | 9.10e-04 | 103 | 9 | 2 | int:TRPC4AP | |
| Interaction | SF3A1 interactions | 9.59e-04 | 471 | 9 | 3 | int:SF3A1 | |
| Interaction | PLG interactions | 9.63e-04 | 106 | 9 | 2 | int:PLG | |
| Interaction | GSPT2 interactions | 9.81e-04 | 107 | 9 | 2 | int:GSPT2 | |
| Interaction | ARL6IP4 interactions | 1.02e-03 | 109 | 9 | 2 | int:ARL6IP4 | |
| Interaction | RSRC1 interactions | 1.07e-03 | 112 | 9 | 2 | int:RSRC1 | |
| Interaction | EIF4A3 interactions | 1.13e-03 | 499 | 9 | 3 | int:EIF4A3 | |
| Interaction | SRSF3 interactions | 1.29e-03 | 522 | 9 | 3 | int:SRSF3 | |
| Interaction | RPS14 interactions | 1.34e-03 | 529 | 9 | 3 | int:RPS14 | |
| Interaction | RPL15 interactions | 1.35e-03 | 530 | 9 | 3 | int:RPL15 | |
| Interaction | PPIG interactions | 1.38e-03 | 127 | 9 | 2 | int:PPIG | |
| Interaction | NKAP interactions | 1.49e-03 | 132 | 9 | 2 | int:NKAP | |
| Interaction | LLGL2 interactions | 1.51e-03 | 133 | 9 | 2 | int:LLGL2 | |
| Interaction | TERF2IP interactions | 1.52e-03 | 552 | 9 | 3 | int:TERF2IP | |
| Interaction | NCBP2 interactions | 1.69e-03 | 141 | 9 | 2 | int:NCBP2 | |
| Interaction | PPHLN1 interactions | 1.81e-03 | 146 | 9 | 2 | int:PPHLN1 | |
| Interaction | DDX24 interactions | 1.89e-03 | 596 | 9 | 3 | int:DDX24 | |
| Interaction | MYCN interactions | 2.05e-03 | 1373 | 9 | 4 | int:MYCN | |
| Interaction | CSNK2B interactions | 2.17e-03 | 625 | 9 | 3 | int:CSNK2B | |
| Interaction | NKAPD1 interactions | 2.20e-03 | 161 | 9 | 2 | int:NKAPD1 | |
| Interaction | RSBN1 interactions | 2.20e-03 | 161 | 9 | 2 | int:RSBN1 | |
| Interaction | NR2C2 interactions | 2.22e-03 | 1403 | 9 | 4 | int:NR2C2 | |
| Interaction | HNRNPC interactions | 2.26e-03 | 634 | 9 | 3 | int:HNRNPC | |
| Interaction | U2AF2 interactions | 2.44e-03 | 651 | 9 | 3 | int:U2AF2 | |
| Interaction | FGF11 interactions | 2.45e-03 | 170 | 9 | 2 | int:FGF11 | |
| Interaction | SSRP1 interactions | 2.82e-03 | 685 | 9 | 3 | int:SSRP1 | |
| Interaction | SREK1 interactions | 2.83e-03 | 183 | 9 | 2 | int:SREK1 | |
| Interaction | SFN interactions | 2.90e-03 | 692 | 9 | 3 | int:SFN | |
| Interaction | TOP1 interactions | 2.95e-03 | 696 | 9 | 3 | int:TOP1 | |
| Interaction | ELAVL2 interactions | 2.98e-03 | 188 | 9 | 2 | int:ELAVL2 | |
| Interaction | WTAP interactions | 3.17e-03 | 194 | 9 | 2 | int:WTAP | |
| Interaction | WDR83 interactions | 3.24e-03 | 196 | 9 | 2 | int:WDR83 | |
| Interaction | SRSF11 interactions | 3.47e-03 | 203 | 9 | 2 | int:SRSF11 | |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_DN | 5.31e-06 | 106 | 9 | 3 | M7988 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 1.25e-05 | 141 | 9 | 3 | M7720 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 2.86e-05 | 186 | 9 | 3 | M4911 | |
| Coexpression | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN | 5.50e-05 | 33 | 9 | 2 | M8981 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 3.69e-04 | 85 | 9 | 2 | M45761 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-04 | 124 | 9 | 2 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-04 | 153 | 9 | 2 | d5f5399ebbbff508c96ce7f01272716b61597ab5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-04 | 153 | 9 | 2 | 32cf4ca828d228f23366480305592f9813fed7ff | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-04 | 156 | 9 | 2 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-04 | 157 | 9 | 2 | beab0ac47202266b04543c02cfcdda012375e879 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 4.40e-04 | 159 | 9 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.85e-04 | 167 | 9 | 2 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-04 | 173 | 9 | 2 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 174 | 9 | 2 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-04 | 175 | 9 | 2 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.38e-04 | 176 | 9 | 2 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 177 | 9 | 2 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-04 | 177 | 9 | 2 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-04 | 181 | 9 | 2 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 181 | 9 | 2 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.69e-04 | 181 | 9 | 2 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-04 | 182 | 9 | 2 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.81e-04 | 183 | 9 | 2 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-04 | 185 | 9 | 2 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.00e-04 | 186 | 9 | 2 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 186 | 9 | 2 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.00e-04 | 186 | 9 | 2 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.07e-04 | 187 | 9 | 2 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.07e-04 | 187 | 9 | 2 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.07e-04 | 187 | 9 | 2 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-04 | 188 | 9 | 2 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-04 | 188 | 9 | 2 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.20e-04 | 189 | 9 | 2 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 189 | 9 | 2 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.20e-04 | 189 | 9 | 2 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.26e-04 | 190 | 9 | 2 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.26e-04 | 190 | 9 | 2 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.26e-04 | 190 | 9 | 2 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-04 | 190 | 9 | 2 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.33e-04 | 191 | 9 | 2 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 191 | 9 | 2 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-04 | 191 | 9 | 2 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 191 | 9 | 2 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-04 | 191 | 9 | 2 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-04 | 191 | 9 | 2 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.39e-04 | 192 | 9 | 2 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-04 | 192 | 9 | 2 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.46e-04 | 193 | 9 | 2 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.46e-04 | 193 | 9 | 2 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.46e-04 | 193 | 9 | 2 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.53e-04 | 194 | 9 | 2 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.53e-04 | 194 | 9 | 2 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.53e-04 | 194 | 9 | 2 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.53e-04 | 194 | 9 | 2 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.53e-04 | 194 | 9 | 2 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.53e-04 | 194 | 9 | 2 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.59e-04 | 195 | 9 | 2 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-04 | 195 | 9 | 2 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 6.59e-04 | 195 | 9 | 2 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.59e-04 | 195 | 9 | 2 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.59e-04 | 195 | 9 | 2 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 195 | 9 | 2 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-04 | 195 | 9 | 2 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-04 | 195 | 9 | 2 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.59e-04 | 195 | 9 | 2 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-04 | 195 | 9 | 2 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-04 | 195 | 9 | 2 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.66e-04 | 196 | 9 | 2 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 196 | 9 | 2 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-04 | 196 | 9 | 2 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.66e-04 | 196 | 9 | 2 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 6.66e-04 | 196 | 9 | 2 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 6.66e-04 | 196 | 9 | 2 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 196 | 9 | 2 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-04 | 196 | 9 | 2 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 196 | 9 | 2 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.66e-04 | 196 | 9 | 2 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.66e-04 | 196 | 9 | 2 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-04 | 196 | 9 | 2 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-04 | 196 | 9 | 2 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-04 | 196 | 9 | 2 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 196 | 9 | 2 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-04 | 197 | 9 | 2 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-04 | 197 | 9 | 2 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.73e-04 | 197 | 9 | 2 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 6.73e-04 | 197 | 9 | 2 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-04 | 197 | 9 | 2 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.73e-04 | 197 | 9 | 2 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.73e-04 | 197 | 9 | 2 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-04 | 197 | 9 | 2 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.73e-04 | 197 | 9 | 2 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-04 | 197 | 9 | 2 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.73e-04 | 197 | 9 | 2 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.80e-04 | 198 | 9 | 2 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.80e-04 | 198 | 9 | 2 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-04 | 198 | 9 | 2 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.80e-04 | 198 | 9 | 2 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.80e-04 | 198 | 9 | 2 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 6.80e-04 | 198 | 9 | 2 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| Drug | alpha-cobratoxin | 1.66e-05 | 16 | 9 | 2 | ctd:C025154 | |
| Drug | Mecamylamine | 1.42e-04 | 46 | 9 | 2 | ctd:D008464 | |
| Drug | Tubocurarine | 3.21e-04 | 69 | 9 | 2 | ctd:D014403 | |
| Drug | benz(a)anthracene | 9.15e-04 | 1251 | 9 | 4 | ctd:C030935 | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; HL60; HG-U133A | 1.91e-03 | 169 | 9 | 2 | 1736_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.02e-03 | 174 | 9 | 2 | 1302_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.09e-03 | 177 | 9 | 2 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.11e-03 | 178 | 9 | 2 | 3998_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.30e-03 | 186 | 9 | 2 | 916_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 4302_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 5233_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.35e-03 | 188 | 9 | 2 | 4545_DN | |
| Drug | AC1Q6AQ7 | 2.35e-03 | 188 | 9 | 2 | CID000005515 | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; HL60; HG-U133A | 2.37e-03 | 189 | 9 | 2 | 1381_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 5223_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4269_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.42e-03 | 191 | 9 | 2 | 1057_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 1792_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 4274_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 2.45e-03 | 192 | 9 | 2 | 1599_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.45e-03 | 192 | 9 | 2 | 993_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 6985_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.47e-03 | 193 | 9 | 2 | 1051_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1957_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4772_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 2900_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4727_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 632_DN | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 2.53e-03 | 195 | 9 | 2 | 1138_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 1903_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4971_UP | |
| Drug | 5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.53e-03 | 195 | 9 | 2 | 889_UP | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.53e-03 | 195 | 9 | 2 | 1132_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 1956_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2036_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2072_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2101_UP | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1959_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3820_UP | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 7139_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1909_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4739_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2331_UP | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 6279_DN | |
| Drug | Prostaglandin E1; Up 200; 10uM; MCF7; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 6576_UP | |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 161_DN | |
| Drug | DAPH; Up 200; 10uM; MCF7; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 624_UP | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; HL60; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 1395_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 1930_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 2110_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; HL60; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 1388_DN | |
| Drug | sulfasalazine; Up 200; 100uM; MCF7; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 204_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 4764_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.60e-03 | 198 | 9 | 2 | 4735_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.60e-03 | 198 | 9 | 2 | 4567_DN | |
| Drug | STOCK1N-35696; Down 200; 15uM; PC3; HT_HG-U133A | 2.60e-03 | 198 | 9 | 2 | 6564_DN | |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; ssMCF7; HG-U133A | 2.60e-03 | 198 | 9 | 2 | 376_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; HL60; HG-U133A | 2.60e-03 | 198 | 9 | 2 | 1378_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.60e-03 | 198 | 9 | 2 | 1650_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.60e-03 | 198 | 9 | 2 | 1002_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.60e-03 | 198 | 9 | 2 | 4729_DN | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 2.60e-03 | 198 | 9 | 2 | 1135_DN | |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 2.60e-03 | 198 | 9 | 2 | 1101_DN | |
| Drug | iloprost; Down 200; 1uM; SKMEL5; HG-U133A | 2.60e-03 | 198 | 9 | 2 | 496_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 7452_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 5535_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 4817_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | 2.63e-03 | 199 | 9 | 2 | 1960_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; HL60; HG-U133A | 2.63e-03 | 199 | 9 | 2 | 1737_DN | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 7246_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 1277_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | 2.63e-03 | 199 | 9 | 2 | 2449_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A | 2.63e-03 | 199 | 9 | 2 | 1890_DN | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HG-U133A | 2.63e-03 | 199 | 9 | 2 | 1936_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A | 2.65e-03 | 200 | 9 | 2 | 1720_DN | |
| Disease | cytotoxicity measurement, response to clozapine | 2.60e-05 | 29 | 8 | 2 | EFO_0006952, GO_0097338 | |
| Disease | lip morphology measurement | 1.11e-03 | 189 | 8 | 2 | EFO_0007845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSVRYSSSKHYSSSR | 1 | P13645 | |
| SRSSYTYSKSRSGST | 696 | Q7Z6E9 | |
| TYSKSRSGSTRSRSY | 701 | Q7Z6E9 | |
| SRSFSRSHSRSYSRS | 716 | Q7Z6E9 | |
| SSYSEYRNSRTSLSR | 5396 | Q96RW7 | |
| KRSFFRSSSSSSRSY | 221 | P10643 | |
| RDSYRSKSHSQSYSR | 516 | P30414 | |
| SSRSRSYSRSYTRSR | 696 | P30414 | |
| SYSRSYTRSRSLASS | 701 | P30414 | |
| HSRSRSRSSTSSYRS | 1336 | P30414 | |
| SRSSTSSYRSRSYSR | 1341 | P30414 | |
| RTRSRSSSYRSYKSH | 1366 | P30414 | |
| SSSYRSYKSHRTSSR | 1371 | P30414 | |
| SYKSHRTSSRSRSRS | 1376 | P30414 | |
| SNSRYSRYHSSRSHS | 196 | Q9BRL6 | |
| YTQSRSTSSEKRSYS | 416 | A7MD48 | |
| STSSEKRSYSRSPSY | 421 | A7MD48 | |
| KKTYSRRTSSHSSSY | 466 | Q9BYW2 | |
| HSSSYRDLRTSSYSK | 476 | Q9BYW2 | |
| RGSSYSKHDSSASRY | 541 | Q9BYW2 | |
| RSRSRSSSYSSYSSR | 571 | Q86VM9 |